Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: Unanswered questions

Norman C. Wang; Jonathan P. Piccini; Mihai Gheorghiade

doi:10.1007/s10741-011-9243-5

Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: Unanswered questions

Norman C. Wang^*, Jonathan P. Piccini, Mihai Gheorghiade

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Implantable cardioverter-defibrillators have proven efficacy in reducing mortality in patients with reduced left ventricular ejection fraction in both the primary and the secondary prevention settings. All randomized trials demonstrating this benefit have been conducted in outpatients with stable heart failure symptoms. Whether implantable cardioverter-defibrillators confer a benefit when implemented in patients with chronically reduced left ventricular ejection fraction in the acute heart failure setting is unknown. The purpose of this document is to review the existing literature related to this subject.

Original language	English (US)
Pages (from-to)	477-480
Number of pages	4
Journal	Heart Failure Reviews
Volume	16
Issue number	5
DOIs	https://doi.org/10.1007/s10741-011-9243-5
State	Published - Sep 1 2011

Keywords

Heart failure
Hospitalization
Implantable cardioverter-defibrillator
Mortality

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s10741-011-9243-5

Cite this

@article{0932e60f605747ea809b9f8f0704b38f,

title = "Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: Unanswered questions",

abstract = "Implantable cardioverter-defibrillators have proven efficacy in reducing mortality in patients with reduced left ventricular ejection fraction in both the primary and the secondary prevention settings. All randomized trials demonstrating this benefit have been conducted in outpatients with stable heart failure symptoms. Whether implantable cardioverter-defibrillators confer a benefit when implemented in patients with chronically reduced left ventricular ejection fraction in the acute heart failure setting is unknown. The purpose of this document is to review the existing literature related to this subject.",

keywords = "Heart failure, Hospitalization, Implantable cardioverter-defibrillator, Mortality",

author = "Wang, {Norman C.} and Piccini, {Jonathan P.} and Mihai Gheorghiade",

year = "2011",

month = sep,

day = "1",

doi = "10.1007/s10741-011-9243-5",

language = "English (US)",

volume = "16",

pages = "477--480",

journal = "Heart Failure Reviews",

issn = "1382-4147",

publisher = "Springer Netherlands",

number = "5",

}

TY - JOUR

T1 - Implantable cardioverter-defibrillator implementation in acute heart failure syndromes

T2 - Unanswered questions

AU - Wang, Norman C.

AU - Piccini, Jonathan P.

AU - Gheorghiade, Mihai

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Implantable cardioverter-defibrillators have proven efficacy in reducing mortality in patients with reduced left ventricular ejection fraction in both the primary and the secondary prevention settings. All randomized trials demonstrating this benefit have been conducted in outpatients with stable heart failure symptoms. Whether implantable cardioverter-defibrillators confer a benefit when implemented in patients with chronically reduced left ventricular ejection fraction in the acute heart failure setting is unknown. The purpose of this document is to review the existing literature related to this subject.

AB - Implantable cardioverter-defibrillators have proven efficacy in reducing mortality in patients with reduced left ventricular ejection fraction in both the primary and the secondary prevention settings. All randomized trials demonstrating this benefit have been conducted in outpatients with stable heart failure symptoms. Whether implantable cardioverter-defibrillators confer a benefit when implemented in patients with chronically reduced left ventricular ejection fraction in the acute heart failure setting is unknown. The purpose of this document is to review the existing literature related to this subject.

KW - Heart failure

KW - Hospitalization

KW - Implantable cardioverter-defibrillator

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=80052498097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052498097&partnerID=8YFLogxK

U2 - 10.1007/s10741-011-9243-5

DO - 10.1007/s10741-011-9243-5

M3 - Review article

C2 - 21424741

AN - SCOPUS:80052498097

SN - 1382-4147

VL - 16

SP - 477

EP - 480

JO - Heart Failure Reviews

JF - Heart Failure Reviews

IS - 5

ER -

Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: Unanswered questions

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this